Abstract
LAR is a widely expressed receptor-like protein tyrosine phosphatase that is implicated in regulation of intracellular signaling triggered by both cell adhesion and peptide growth factors. Genetic studies revealed that LAR regulates neuron axon path finding in Drosophila and mammary gland epithelial cell differentiation in mice. The molecular mechanism underlying the tissue specific function of LAR has not been clearly understood. We investigated the role and mechanism of LAR in peptide growth factors EGF and FGF signaling in human tissue culture cells in which the expression of LAR is under the control of an inducible promoter. We found that although both EGF and FGF induce activation of mitogen-activated protein kinase (MAPK), LAR only inhibits FGF-induced MAPK activation. LAR does not interact directly with the peptide growth factor receptors, since the ligand-induced autophosphorylation of growth factor receptors was not affected by induction of LAR. The specific effect of LAR on FGF-induced MAPK activation appeared to be mediated by specific inhibition of the phosphorylation of two signal transducers that act downstream of the FGF receptor, FRS2 and a 180 kDa protein, and by prevention of their interaction with the adaptor protein GRB2. In contrast, LAR selectively inhibited the epidermal growth factor (EGF)-induced phosphorylation of p130CAS and the formation of the complex between p130CAS and GRB2 but this effect did not influence the activation of MAPK by EGF. These data suggest that LAR and similar receptor-like protein tyrosine phosphatases may contribute to the regulation of transmembrane signaling by selectively inhibiting the tyrosine phosphorylation of specific signal transducers that act downstream of the plasma membrane-associated tyrosine kinases. The consequent inhibition of the formation of signaling complexes by these proteins may contribute to the specificity of the signals generated by specific peptide growth factors as well as extracellular matrix proteins.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ahmad F and Goldstein BJ . 1997 J Biol Chem 272: 448–457
Ahn NG . 1993 Mol Cell Biochem 127–128: 201–209
Boonstra J, Rijken P, Humbel B, Cremers F, Verkleij A and van Bergen en Henegouwen P . 1995 Cell Biol Int 19: 413–430
Carpenter G and Cohen S . 1990 J Biol Chem 265: 7709–7712
Chao MV . 1992 Cell 68: 995–997
Cobb MH . 1999 Prog Biophys Mol Biol 71: 479–500
Cohen GB, Ren R and Baltimore D . 1995 Cell 80: 237–248
Denu JM, Lohse DL, Vijayalakshmi J, Saper MA and Dixon JE . 1996 Proc Natl Acad Sci USA 93: 2493–2498
Desai CJ, Gindhart Jr JG, Goldstein LS and Zinn K . 1996 Cell 84: 599–609
Elchebly M, Wagner J, Kennedy TE, Lanctot C, Michaliszyn E, Itie A, Drouin J and Tremblay ML . 1999 Nat Genet 21: 330–333
Fantl WJ, Johnson DE and Williams LT . 1993 Annu Rev Biochem 62: 453–481
Imamura T, Tokita Y and Mitsui Y . 1988 Biochem Biophys Res Commun 155: 583–590
Katsura H, Williams MC, Brody JS and Yu Q . 1995 Developmental Dynamics 204: 89–97
Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I and Schlessinger J . 1997 Cell 89: 693–702
Krueger NX, Van Vactor D, Wan HI, Gelbart WM, Goodman CS and Saito H . 1996 Cell 84: 611–622
Kulas DT, Goldstein BJ and Mooney RA . 1996 Journal of Biological Chemistry 271: 748–754
Kulas DT, Zhang WR, Goldstein BJ, Furlanetto RW and Mooney RA . 1995 Journal of Biological Chemistry 270: 2435–2438
Lewis TS, Shapiro PS and Ahn NG . 1998 Adv Cancer Res 74: 49–139
Li PM, Zhang WR and Goldstein BJ . 1996 Cellular Signalling 8: 467–473
Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D and Schlessinger J . 1992 Cell 70: 431–442
Marshall CJ . 1995 Cell 80: 179–185
Mooney RA, Kulas DT, Bleyle LA and Novak JS . 1997 Biochem Biophys Res Commun 235: 709–712
Muller T, Choidas A, Reichmann E and Ullrich A . 1999 J Biol Chem 274: 10173–10183
O'Grady P, Thai TC and Saito H . 1998 J Cell Biol 141: 1675–1684
Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Grignani F, Pawson T and Pelicci PG . 1992 Cell 70: 93–104
Rabin SJ, Cleghon V and Kaplan DR . 1993 Mol Cell Biol 13: 2203–2213
Schaapveld RQ, Schepens JT, Robinson GW, Attema J, Oerlemans FT, Fransen JA, Streuli M, Wieringa B, Hennighausen L and Hendriks WJ . 1997 Dev Biol 188: 134–146
Schlessinger J . 1994 Curr Opin Genet Dev 4: 25–30
Seger R and Krebs EG . 1995 Faseb J 9: 726–735
Suarez Pestana E, Tenev T, Gross S, Stoyanov B, Ogata M and Bohmer FD . 1999 Oncogene 18: 4069–4079
van der Geer P, Hunter T and Lindberg RA . 1994 Annu Rev Cell Biol 10: 251–337
Wallace MJ, Batt J, Fladd CA, Henderson JT, Skarnes W and Rotin D . 1999 Nat Genet 21: 334–338
Wells A . 1999 Int J Biochem Cell Biol 31: 637–643
Weng LP, Wang X and Yu Q . 1999 Genes Cells 4: 185–196
Weng LP, Yuan J and Yu Q . 1998 Curr Biol 8: 247–256
Xu H, Lee KW and Goldfarb M . 1998 J Biol Chem 273: 17987–17990
Yu Q, Lenardo T and Weinberg RA . 1992 Oncogene 7: 1051–1057
Zinn K . 1998 Curr Biol 8: R725–R726
Acknowledgements
This work was supported by NIH grant R01 HL 54044 from the National Heart, Lung, and Blood Institute.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, X., Weng, LP. & Yu, Q. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR. Oncogene 19, 2346–2353 (2000). https://doi.org/10.1038/sj.onc.1203558
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203558
Keywords
This article is cited by
-
Homozygous truncating PTPRF mutation causes athelia
Human Genetics (2014)
-
CAS proteins in normal and pathological cell growth control
Cellular and Molecular Life Sciences (2010)
-
Three clinical variants of gastroesophageal reflux disease form two distinct gene expression signatures
Journal of Molecular Medicine (2006)
-
Subcellular localization of basic fibroblast growth factor and fibroblast growth factor receptor 1 in pituitary adenomas
Brain Tumor Pathology (2002)
-
Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor
Oncogene (2001)